Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
As global soccer fever builds, 10 Barrel Brewing and Pub Beer are bringing fans together across the Pacific Northwest with watch parties, game-day limited-edition merch and activations, sweepstakes and more
24 American Craft Beer Favourites from Tilray, the 4th Largest Craft Brewer in the U.S., Including SweetWater, Montauk, 10 Barrel, Shock Top, Alpine, Green Flash, Blue Point and More... Debut at BrewDog Bars and Online
New Brand Combines Proven Genetics, German Cultivation Expertise, and Rigorous Quality Standards to Support Patients and Healthcare Professionals Across Germany
Two of the top multi-state operators have seen their shares jump since reclassifying news came out, but they may no longer be the best cannabis stocks to buy.
As Atlanta welcomes the world for a summer of international soccer, SweetWater is bringing fans together through citywide activations, stadium experiences, watch parties and exclusive collaborations.
BrewDog Launches Multi-Channel “Underdog” Campaign Across Retail, Bars and Digital Media — Including a Nationwide “Win a Year of Beer” Contest and Destination Match-Day Watch Parties Across the U.K.
Indiana legislators may soon return to discussions surrounding medical cannabis, though state officials say there is still uncertainty about whether federal action will prompt any immediate changes in state policy.
Indiana legislators may soon return to discussions surrounding medical cannabis, though state officials say there is still uncertainty about whether federal action will prompt any immediate changes in state policy.
